There are many similarities between pharmaceutical patents in the United States and Canada, but there are also many differences – particularly when it comes to litigation. Join our panel consisting of US and Canadian attorneys for a compare and contrast, looking at the related patent litigation schemes for the two countries and how regulatory systems interact with such things as generic competition to innovator drugs.Presented by: Jeffrey I.D. Lewis, Foley Hoag LLP, Mital Patel, Foley Hoag LLP, Brian R. Daley, Norton Rose Fulbright, and Christopher A. Guerreiro, Norton Rose Fulbright
This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. CLE is included for our All Access Pass holders and Corporate Subscribers.